In 2007, drug maker Cephalon sent a letter to pain management specialists reminding them that its potent painkiller Fentora should only be used to manage breakthrough pain in cancer patients who are already taking and are known to be tolerant to opioids, painkillers in the same class as morphine. Cephalon informed these health care professionals that some patients had died while using Fentora and some serious adverse events occurred because of what the company called “improper patient selection (e.g. use in opioid non-tolerant patients), improper dosing, and/or improper product substitution.” Reports revealed that two deaths occurred in patients given Fentora to treat headaches. A third person died because he took the wrong dose, and a fourth patient took the drug to commit suicide.

The Food and Drug Administration (FDA) never approved use of Fentora beyond the treatment of breakthrough pain in opioid-tolerant cancer patients. Yet, it was revealed that Cephalon actively paid doctors to inform other health care professionals of the off-label use of Fentora to treat everything from headaches, backaches and injuries. While off-label prescribing by doctors is not illegal, off-label marketing is. And the results were fatal.

Fentora contains the active ingredient fentanyl, a controlled substance with a high potential for abuse and overdose, which leads to respiratory depression and death. In its letter to health care professionals, Cephalon informed physicians that they should be aware of the potential for misuse when prescribing any drug, and in the case of Fentora and other opioids, to be extra careful because of the high potential for misuse, abuse, or diversion of these substances.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Fentanyl patches recalled due to accelerated release...

Potent pain patches used to treat breakthrough pain in cancer patients already on around-the-clock pain...

Fentanyl patches recalled due to danger of overdose

Potent pain patches used to treat breakthrough pain in cancer patients already on around-the-clock pain...

Cephalon files petition to block Fentora competition

Cephalon, maker of the potent pain killer Fentora, has filed a citizen petition to the Food and Drug...

56 dead from one clinic after taking Actiq for...

Fifty-six patients from one health care clinic have died and 96 others were sent to the emergency room...

FDA approves painkiller designed to be more difficult...

The Food and Drug Administration (FDA) has approved a new version of the painkiller OxyContin that is...

Types of potent painkillers approved only with...

When the Food and Drug Administration (FDA) approved the new opioid medication, Onsolis, last summer,...

Respectful, understanding, efficient and compassionate

Beasley Allen is one of the most professional organizations I have ever had the pleasure of working with. They are respectful, understanding, efficient, and above all compassionate. They take the best care of their clients in every way possible. They keep us informed and aware of things involved in their clients cases. Their counsel is stellar in the industry. I would highly recommend them to others in their time of need and I have done so.

—Chad